Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1294.32 | 653 / 653 | 99% | 10.79 | 601 / 605 |
stomach | 100% | 1248.18 | 358 / 359 | 98% | 15.76 | 281 / 286 |
pancreas | 99% | 507.86 | 324 / 328 | 99% | 12.79 | 176 / 178 |
breast | 100% | 1904.84 | 459 / 459 | 96% | 10.36 | 1068 / 1118 |
intestine | 100% | 1626.89 | 965 / 966 | 91% | 9.86 | 479 / 527 |
esophagus | 97% | 881.10 | 1398 / 1445 | 92% | 13.66 | 168 / 183 |
lung | 99% | 1047.59 | 575 / 578 | 88% | 8.86 | 1020 / 1155 |
prostate | 100% | 971.80 | 244 / 245 | 83% | 4.55 | 418 / 502 |
ovary | 90% | 748.91 | 162 / 180 | 92% | 7.05 | 396 / 430 |
bladder | 100% | 830.67 | 21 / 21 | 78% | 5.52 | 392 / 504 |
uterus | 100% | 893.76 | 170 / 170 | 78% | 5.08 | 356 / 459 |
liver | 92% | 475.07 | 208 / 226 | 76% | 5.05 | 307 / 406 |
skin | 72% | 880.62 | 1308 / 1809 | 93% | 28.32 | 438 / 472 |
kidney | 66% | 343.96 | 59 / 89 | 87% | 8.25 | 780 / 901 |
brain | 58% | 298.78 | 1540 / 2642 | 86% | 5.88 | 604 / 705 |
adrenal gland | 79% | 306.46 | 204 / 258 | 49% | 2.78 | 112 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.65 | 29 / 29 |
spleen | 100% | 2784.57 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1482.59 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 874.70 | 1296 / 1335 | 0% | 0 | 0 / 0 |
muscle | 93% | 534.32 | 749 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 1190.40 | 808 / 929 | 0% | 0 | 0 / 0 |
heart | 85% | 549.27 | 730 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 8.76 | 38 / 45 |
eye | 0% | 0 | 0 / 0 | 16% | 0.73 | 13 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0014904 | Biological process | myotube cell development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0006974 | Biological process | DNA damage response |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0001816 | Biological process | cytokine production |
GO_0033173 | Biological process | calcineurin-NFAT signaling cascade |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_1905064 | Biological process | negative regulation of vascular associated smooth muscle cell differentiation |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_1901741 | Biological process | positive regulation of myoblast fusion |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0051216 | Biological process | cartilage development |
GO_0016477 | Biological process | cell migration |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035976 | Cellular component | transcription factor AP-1 complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0003682 | Molecular function | chromatin binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0019902 | Molecular function | phosphatase binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NFATC2 |
Protein name | Nuclear factor of activated T-cells c2 isoform IA-IIS-deltaXa (Nuclear factor of activated T-cells c2 isoform IB-IIS-deltaXa) Nuclear factor of activated T-cells, cytoplasmic 2 (NF-ATc2) (NFATc2) (NFAT pre-existing subunit) (NF-ATp) (T-cell transcription factor NFAT1) |
Synonyms | NFAT1 NFATP |
Description | FUNCTION: Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2, IL-3, IL-4, TNF-alpha or GM-CSF . Promotes invasive migration through the activation of GPC6 expression and WNT5A signaling pathway . Is involved in the negative regulation of chondrogenesis . . |
Accessions | ENST00000609943.5 [Q13469-4] ENST00000396009.7 [Q13469-1] ENST00000610033.5 [Q13469-5] B5B2P4 ENST00000371564.8 [Q13469-2] Q13469 ENST00000609507.1 [Q13469-5] ENST00000414705.5 [Q13469-3] |